Status:
TERMINATED
Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures
Lead Sponsor:
Cyberonics, Inc.
Conditions:
Epilepsies, Partial
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
To compare outcomes over 12 months of treatment with antiepileptic drugs (AEDs) alone or vagus nerve stimulation (VNS) therapy plus AEDs in patients who have partial seizures refractory to at least tw...
Detailed Description
Published data suggest that patients who continue to experience seizures after trials of two or three AEDs are unlikely to become seizure-free with further attempts at pharmacotherapy. Such patients m...
Eligibility Criteria
Inclusion
- Patient has a diagnosis of partial seizures with onset before age 50, and the patient's prior electroencephalography and magnetic resonance imaging studies are consistent with the diagnosis of partial seizures.
- Patient has at least 4 complex partial seizures, but less than 25 seizures (any type), per month during the 3 months preceding randomization; for the 8 weeks preceding randomization, the seizure frequency should be confirmed from a patient diary.
- Patient has not had an adequate response to an adequate dosage of -- or was intolerant to -- a minimum of 2 different AEDs.
- Patient has (in the investigator's judgment) sufficient impairment from his/her epilepsy and/or epilepsy treatment that the potential benefits/risks of VNS therapy are warranted.
- Patient must currently be receiving at least one AED, but not more than three AEDs, in a stable dosage regimen for at least one month before randomization.
- Patient must be 12 years of age or older.
- Patient must be able to provide reliable seizure counts and to complete the evaluations specified in the study procedures flow chart.
- Patient must provide written informed consent, or legal guardian must give written permission and the minor provide written assent.
Exclusion
- Patient has a history (lifetime) of having received more than 5 different AEDs.
- Patient has had a bilateral or left cervical vagotomy.
- Patient currently uses, or is expected to use during the study, short-wave diathermy, microwave diathermy, or therapeutic ultrasound diathermy.
- A VNS Therapy System implant would (in the investigator's judgment) pose an unacceptable surgical or medical risk for the patient.
- Patient is expected to require full body magnetic resonance imaging during the clinical study.
- Patient has had a previous VNS Therapy System implant.
- Patient has a previous neuroimaging study that demonstrates mesial temporal sclerosis, cortical dysplasia, or a suspected brain tumor.
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2007
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00215215
Start Date
February 1 2005
End Date
November 1 2007
Last Update
February 22 2006
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Bronislav Shafran, M.D., P.C.
Phoenix, Arizona, United States, 85003
2
Xenoscience
Phoenix, Arizona, United States, 85013
3
Dedicated Clinical Research, Inc.
Sun City, Arizona, United States, 85351
4
USC Comprehensive Epilepsy Center
Los Angeles, California, United States, 90033